The MitoPark Mouse - An animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons

Parkinsonism and Related Disorders

Volumn 15, Issue SUPPL. 3, 2009, Pages

  Ekstrand, Mats I ^a   Galter, Dagmar ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Animal Models; Dopamine; L DOPA; Mitochondria; Mouse; Parkinson's disease; Tfam

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PARKIN;

ARTICLE; CELL AGGREGATION; CLINICAL FEATURE; CORPUS STRIATUM; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENZYME INACTIVATION; EXPERIMENTAL MODEL; MESENCEPHALON; MITOCHONDRIAL RESPIRATION; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOPAMINE; ELECTRON TRANSPORT; HUMANS; LEVODOPA; MICE; MICE, TRANSGENIC; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; NEURONS; PARKINSON DISEASE; TRANSCRIPTION FACTORS;

EID: 71849092169     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70811-9     Document Type: Article

References (26)

1. Terzioglu M., and Galter D. Parkinson's disease: genetic versus toxin-induced rodent models. FEBS J 275 7 (2008 Apr) 1384-1391
2. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 6 (2003 Sep 11) 889-909
3. Cicchetti F., Drouin-Ouellet J., and Gross R.E. Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?. Trends Pharmacol Sci 30 9 (2009 Sep) 475-483
4. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318 1 (2004 Oct) 215-224
5. Bender A., Krishnan K.J., Morris C.M., Taylor G.A., Reeve A.K., Perry R.H., et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38 5 (2006 May) 515-517
6. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441 7097 (2006 Jun 29) 1162-1166
7. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441 7097 (2006 Jun 29) 1157-1161
8. Shen J., and Cookson M.R. Mitochondria and dopamine: new insights into recessive parkinsonism. Neuron 43 3 (2004 Aug 5) 301-304
9. Goldberg M.S., Fleming S.M., Palacino J.J., Cepeda C., Lam H.A., Bhatnagar A., et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278 44 (2003 Oct 31) 43628-43635
10. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45 4 (2005 Feb 17) 489-496
11. Kitada T., Pisani A., Porter D.R., Yamaguchi H., Tscherter A., Martella G., et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA 104 27 (2007 Jul 3) 11441-11446
12. Fleming S.M., Fernagut P.O., and Chesselet M.F. Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2 3 (2005 Jul) 495-503
13. Lu X.H., Fleming S.M., Meurers B., Ackerson L.C., Mortazavi F., Lo V., et al. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 29 7 (2009 Feb 18) 1962-1976
14. Li Y., Liu W., Oo T.F., Wang L., Tang Y., Jackson-Lewis V., et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12 7 (2009 Jul) 826-828
15. von Bohlen und Halbach O. Modeling neurodegenerative diseases in vivo review. Neurodegener Dis 2 6 (2005) 313-320
16. Wredenberg A., Wibom R., Wilhelmsson H., Graff C., Wiener H.H., Burden S.J., et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA 99 23 (2002 Nov 12) 15066-15071
17. Sorensen L., Ekstrand M., Silva J.P., Lindqvist E., Xu B., Rustin P., et al. Late onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci 21 20 (2001 Oct 15) 8082-8090
18. Silva J.P., Kohler M., Graff C., Oldfors A., Magnuson M.A., Berggren P.O., et al. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 26 3 (2000 Nov) 336-340
19. Wang J., Wilhelmsson H., Graff C., Li H., Oldfors A., Rustin P., et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 21 1 (1999 Jan) 133-137
20. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18 3 (1998 Mar) 231-236
21. Ekstrand M.I., Terzioglu M., Galter D., Zhu S., Hofstetter C., Lindqvist E., et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104 4 (2007 Jan 23) 1325-1330
22. Hauser R.A. Levodopa: past, present, and future. Eur Neurol 62 1 (2009) 1-8
23. Galter D, Pernold K, Yoshitake T, Lindqvist E, Hoffer B, Kehr J, et al. MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease. Genes Brain Behav 2009; in press.
24. Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102 9 (2005 Mar 1) 3413-3418
25. Sherer T.B., Kim J.H., Betarbet R., and Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179 1 (2003 Jan) 9-16
26. Dufour E., Terzioglu M., Sterky F.H., Sorensen L., Galter D., Olson L., et al. Age-associated mosaic respiratory chain deficiency causes trans-neuronal degeneration. Hum Mol Genet 17 10 (2008 May 15) 1418-1426